Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values

OBJECTIVE: The aim of the study was to analyze John Cunningham virus (JCV) serology in natalizumab-treated patients over time and assess whether they are influenced by natalizumab treatment. METHODS: German (n = 1,921; 525 longitudinally) and French (n = 1,259; 711 longitudinally) patients were asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Nicholas, Schneider-Hohendorf, Tilman, Pignolet, Béatrice, Breuer, Johanna, Gross, Catharina C., Göbel, Kerstin, Brassat, David, Wiendl, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733149/
https://www.ncbi.nlm.nih.gov/pubmed/26848486
http://dx.doi.org/10.1212/NXI.0000000000000195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733149/
https://www.ncbi.nlm.nih.gov/pubmed/26848486
http://dx.doi.org/10.1212/NXI.0000000000000195

Ejemplares similares